COVID-19

Medicare and Medicaid will continue to cover the cost of COVID-19 vaccines after the Public Health Emergency ends. There may be a co-pay for receiving a vaccine, depending on your insurance plan. Check with your insurance company if you have questions about the cost of receiving a COVID-19 vaccine.

Starting May 12, mandatory insurance coverage for COVID-19 testing will end. Your insurance company will continue to cover the cost of testing when a provider orders the test, and you have been exposed or have symptoms. You may not be covered for elective testing, such as for travel.

Starting May 12, most insurance companies will no longer reimburse you for buying at-home COVID-19 tests. If you want to purchase at-home COVID-19 tests before insurance reimbursement ends, you can purchase them from your local pharmacy or online.

There is no change in coverage for COVID-19 treatment. If you are paying a deductible or cost share for these treatments now, then you will continue to pay these costs after the end of the Public Health Emergency.

During the COVID-19 Public Health Emergency, you may have been able to get a prescription for a controlled substance during a virtual or telehealth visit. Starting on May 12, you may need to have had an in-person visit within the last two years to continue to get prescriptions for controlled substances via a virtual or telehealth visit. You also may need an in-person visit before receiving a first-time controlled substance prescription. Ask your care team if this applies to you.